Comparison of the effects of raloxifene and low-dose hormone.
OBJECTIVE The aim of the present study was to compare the effects of raloxifene and low-dose hormone replacement therapy HRT on bone mineral density. Eur J Endocrinol. 2004 Apr;1504539-46. Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men. Duschek. Jun 24, 2015. Raloxifene works by mimicking the natural effects of oestrogen. The female hormone oestrogen helps to protect a woman against bone loss.
Effects of raloxifene on gonadotrophins, sex hormones, bone. - NCBI
Hormone Replacement Therapy; Bisphosphonates - Fosamax alendronate and Actonel risedronate sodium; Evista raloxifene; Fosamax alendronate. Sep 15, 1999. The search for the most optimal post-menopausal hormone replacement therapy HRT is rapidly becoming one of the most widely pursued. Raloxifene, a nonsteroidal benzothiophene, is a second-generation selective estrogen receptor modulator SERM that is an antiresorptive agent. Raloxifene is.
Raloxifene for osteoporosis; Evista. Information and side effects.
Jul 12, 2006. Even as Evista raloxifene reduced the risk of invasive breast. Evista did not reduce the risk of estrogen-negative breast cancers P=0.40. Combining bisphosphonates with hormone therapy for postmenopausal. study of a selective estrogen receptor modulator raloxifene in combination with a.
Risks and Benefits of 5 Osteoporosis Medications - Health After 50
Jun 10, 2016. Raloxifene Evista is a member of the estrogen agonists/antagonists class of drugs, more commonly referred to as selective estrogen receptor. The objective of the study was to evaluate the effects of raloxifene and estrogen progesterone E + P combination on symptoms, endometrium, and lipid profile.